AmCad BioMed vs Bora: monthly revenue

Monthly revenue and year-on-year change for AmCad BioMed (4188) and Bora (6472) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ AmCad BioMed ━ Bora

0%+59%-84%25/1026/0126/0426/0726/10

Monthly revenue history

MonthAmCad BioMedYoYBoraYoY
Oct 2026NT$2.1 million-16.6%NT$1.99 billion+15.9%
Sep 2026NT$2.3 million-62.2%NT$2.33 billion+35.1%
Aug 2026NT$2.4 million+2.9%NT$2.18 billion+59.2%
Jul 2026NT$3.3 million+56.5%NT$1.9 billion+5.8%
Jun 2026NT$1.9 million-38.3%NT$2.3 billion+39.2%
May 2026NT$2.2 million-8.7%NT$2.11 billion+40.2%
Apr 2026NT$2.7 million-3.0%NT$1.48 billion-27.5%
Mar 2026NT$1.9 million-13.1%NT$1.53 billion+6.3%
Feb 2026NT$1.6 million-31.6%NT$1.33 billion-23.2%
Jan 2026NT$2.9 million+26.5%NT$1.14 billion-30.2%
Dec 2025NT$1.2 million-84.3%NT$1.66 billion-16.6%
Nov 2025NT$1.3 million-81.1%NT$1.5 billion-10.8%
Oct 2025NT$2.5 million-25.6%NT$1.72 billion-17.8%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16